Aurobindo Pharma has announced that it has reached a definitive agreement to sell its subsidiary – Natrol LLC to New Mountain Capital, which will combine it with Jarrow Formulas. This transaction is expected to close by January 2021 subject to customary closing conditions and regulatory approvals. The pharma firm is looking to use the proceeds…